13-12-2022 18:00 via medpagetoday.com

High-Dose Chemo, ASCT Improves Survival in Primary CNS Lymphoma

(MedPage Today) -- NEW ORLEANS--High-dose chemotherapy followed by transplant as consolidation treatment for primary central nervous system (CNS) lymphoma prolonged survival compared with a non-myeloablative regimen, an international phase...
Read more »